kabutan

Nxera Pharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.

Fri Feb 13, 2026 3:30 pm JST Earnings

4565 Nxera Pharma Co., Ltd. 【IFRS】

Earnings Report

Nxera Pharma Co., Ltd. <4565> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 13th (15:30). The consolidated net loss for the fiscal year ended December 2025 expanded to a loss of 12.5 billion yen (compared to a loss of 4.83 billion yen in the previous period). This marks the third consecutive term of losses. Furthermore, the company projects revenue in the range of 33.8 billion to 48.8 billion yen for the fiscal year ending December 2026.

In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 7.72 billion yen (compared to a loss of 1.33 billion yen in the same period last year). However, the operating profit/loss margin significantly improved from -37.6% in the same period last year to -32.9%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 12,766 -9,526 -10,680 -7,193 -87.2 0 Feb 13, 2024 IFRS
Dec, 2024 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
Dec, 2025 29,615 -8,462 -14,950 -12,530 -138.8 0 Feb 13, 2026 IFRS
YoY +2.7% -56.0% -220.7% -159.0% -157.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
Dec, 2025 Results 29,615 -8,462 -14,950 -12,530 -138.8 0 Feb 13, 2026 IFRS
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 15,094 -2,756 -3,722 -3,137 -34.8 0 Aug 8, 2025 IFRS
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
Dec, 2025 29,615 -8,462 -14,950 -12,530 -138.8 0 Feb 13, 2026 IFRS
Dec, 2026 Guidance 41,300 8,200 ー ー － 0 Feb 13, 2026 IFRS
YoY +39.5% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 6,852 -2,577 -2,369 -1,335 -14.9 -37.6 Feb 14, 2025 IFRS
Jan - Mar, 2025 6,644 -2,193 -2,156 -760 -8.5 -33.0 May 2, 2025 IFRS
Apr - Jun, 2025 8,450 -563 -1,566 -2,377 -26.4 -6.7 Aug 8, 2025 IFRS
Jul - Sep, 2025 6,754 -3,151 -3,116 -1,672 -18.5 -46.7 Oct 31, 2025 IFRS
Oct - Dec, 2025 7,767 -2,555 -8,112 -7,721 -85.5 -32.9 Feb 13, 2026 IFRS
YoY +13.4% +0.9% -242.4% -478.4% -474.8%

Related Articles